Scioderm Garners $16,000,000 Series A Funding

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    9650 Strickland Road Raleigh, NC 27615 USA
  • Company Description
    The core business focus of Scioderm is the development of innovative dermatological drugs. Our strategy is to in-license or acquire early to mid-stage pharmaceutical products with the intent to develop the topical products.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series A
  • Proceeds Purposes
    With the proceeds from the Series A investment, Scioderm intends to advance SD-101, a topical cream with a unique mechanism of action, into clinical development through registration for the treatment of the severe skin effects seen in patients across all EB subtypes.
  • M&A Terms
  • Venture Investor
  • Venture Investor

Trending on Xconomy